INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

74,179 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TJ
Turner David Jackson Jr.Director
DECDiversified Energy Co
Grant or award
A—
230 sh
Sep 30, 2026Oct 1, 2026
Page 343 of 1855
← PrevNext →
traded Sep 30, 2026
+1d
SEC Form 4

Evidence

9
PD
Porteous William D.Director
BKSYBlackSky Technology Inc.
Grant or award
A—
1,055 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
SR
Sterling Brian RDirector
PIPRPIPER SANDLER COMPANIES
Grant or award
A—
383 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
CJ
Cole James Jr.Director
AIGAMERICAN INTERNATIONAL GROUP, INC.
Grant or award
A—
126 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

9
ML
McKay LamarDirector
APAAPA Corp
Grant or award
A—
1,804 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
HB
Hoffmeister BruceSVP, Chief Information Officer
CBRLCRACKER BARREL OLD COUNTRY STORE, INC
Option exercise
M—
663 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
AGNTAGNT, Inc.
Grant or award
A$1,529
391 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
SB
Sullivan BenjaminSr EVP, Chief Legal Officer
DECDiversified Energy Co
Grant or award
A—
4,095 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
JD
Jin DavidChief Financial Officer
FBIOFortress Biotech, Inc.
Grant or award
A$2,165
1,190 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

9
GC
Gallo Ann CDirector
PIPRPIPER SANDLER COMPANIES
Grant or award
A—
383 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

9
GM
Golem Lucas M.CHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Disposition to issuer
D$139
3 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

8
GA
Gartelmann Richard A JREVP
OSBCOLD SECOND BANCORP INC
Other acquisition or disposition
J—
35 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

8
PJ
Pursley JamesPresident
HNGEHinge Health, Inc.
Tax withholding
F$81K
831 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

8
RE
Rcb Equities 1, Llc10% Owner
KITTNauticus Robotics, Inc.
Derivative conversion
C—Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

7
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
8,100 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

6
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Grant or award
A—
11.6K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

6
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Grant or award
A—
7,222 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

5
CC
Carr ChrisDirector
HLTHilton Worldwide Holdings Inc.
Grant or award
A—
3 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

5
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Grant or award
A$637
9 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

5
GM
Gray Jonice MDirector
VACMARRIOTT VACATIONS WORLDWIDE Corp
Grant or award
A—
105 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

5
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M$353K
6,000 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

5
DM
Daniels Ryan M.SVP, Wood Products
RYNRAYONIER INC
Open-market sale · 10b5-1 plan
SELL$16K
887 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$772K
5,308 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$359K
2,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

3
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

2
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$438K
17.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

2
BP
Brown Jameson PruittDirector, TREASURER, 10% Owner
NENNEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Other acquisition or disposition · 10b5-1 plan
J$25K
15 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

2
BP
Brown Jameson PruittDirector, TREASURER, 10% Owner
NENNEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Other acquisition or disposition · 10b5-1 plan
J$660
0 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
776 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
GK
Grant Laura KDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$7,505
367 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
17.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$9,195
233 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

0
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M—
6,000 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
324 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
WG
Whalen Thomas GerardDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$2,515
123 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
SG
Schiller Derek GordonEVP, Business
BATRKAtlanta Braves Holdings, Inc.
Option exercise · 10b5-1 plan
M—
175.4K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
HJ
Heller Gregory JohnEVP, CLO & Secretary
BATRKAtlanta Braves Holdings, Inc.
Option exercise · 10b5-1 plan
M—
80.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence